iohexol has been researched along with butyryl-n-trihexylcitrate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayer, G; Byrne, RA; Hartwig, S; Joner, M; Joost, A; Radke, PW; Steigerwald, K; Wittchow, E | 1 |
Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F | 1 |
2 other study(ies) available for iohexol and butyryl-n-trihexylcitrate
Article | Year |
---|---|
Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
Topics: Angioplasty, Balloon, Coronary; Animals; Butyrates; Cardiovascular Agents; Citrates; Coated Materials, Biocompatible; Coronary Angiography; Coronary Vessels; Equipment Design; Excipients; Female; Iohexol; Lecithins; Male; Models, Animal; Paclitaxel; Sus scrofa; Time Factors; Wound Healing | 2011 |
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |